Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

AUPH — Aurinia Pharmaceuticals Inc.

EXPENSIVE (MOS -52.2%) · Quality 100/100

Value Score 30 days ago: 26 → today 29.8

AUPH - Aurinia Pharmaceuticals Inc.
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 16.21 USD
Intrinsic value: 10.65 USD
Margin of safety: -52.2%
Implied growth (reverse DCF): +26.0% (model assumes +17.6%)
Valuation: EXPENSIVE
Value Score: 29.8
Quality: 100/100
Moat score: 51.2 (erosion: none)
EXPENSIVE (MOS -52.2%) - Quality 100/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/AUPH
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

16.21

Intrinsic value

10.65

Margin of safety

-52.2%

Implied growth (reverse DCF)

+26.0%

model assumes +17.6%

Value Score

29.8

Quality

100

Psychology

6.6

Discovery

22.9

price/volume attention only

Moat score

51.2

erosion: none

Value Score: top 45% of Russell 3000 · Quality: top 1%

Open the interactive Deep Dive for AUPH →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/AUPH - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is AUPH undervalued?

As of 2026-11-11, AUPH trades at 16.21 against a computed intrinsic value of 10.65 (-52.2% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Aurinia Pharmaceuticals Inc.'s Value Score?

Aurinia Pharmaceuticals Inc.'s Value Score is 29.8 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.